While the news that Gap (NYSE: GPS ) is planning on taking its Old Navy brand to China wasn't surprising, investors might not have foreseen the strength the company has in its convictions. On a call with investors yesterday, Gap's management said, "We see [the opportunity for global growth] particularly in some countries where in our category, you're talking about double-digit growth just to keep up with the market." That means China, Indonesia, Vietnam, and Cambodia, just to name a few.
The start of the push will come from franchise Old Navy locations in China, but with Gap's impressive array of brands, it's not going to be long before others come along.
The new opportunity
Gap is looking at Old Navy to be the first big push into new Asian markets. At first, stores will be franchise locations, with up to 85 open before the end of the year, with 10 of those being outlets. One of the biggest strengths that the company boasts is its impressive underlying operations. On yesterday's call, the company bragged that the structure now in place was buried in the P&L from 2008 to 2012, and now the cost to enter new locations is minimal.
Top 5 Financial Stocks To Invest In 2015: Diageo plc(DEO)
Diageo plc engages in producing, distilling, brewing, bottling, packaging, distributing, developing, and marketing spirits, beer, and wine products worldwide. It offers a range of brands, including Johnnie Walker scotch whiskies, Smirnoff vodka and Smirnoff ready to drink products, Baileys Original Irish Cream liqueur, Crown Royal Canadian whisky, Captain Morgan rum and rum based products, Jose Cuervo tequila, JeB scotch whisky, Buchanan?s scotch whisky, Windsor Premier scotch whisky, Ketel One vodka, Ciroc vodka, Tanqueray gin, Bushmills Irish whiskey, and Guinness stout. The company also provides other spirits brands that comprise Gordon?s gin and vodka, Old Parr scotch whisky, Bell?s scotch whisky, The Classic Malts scotch whiskies, Seagram?s 7 Crown whiskey and Seagram?s VO whisky, Cacique rum, White Horse scotch whisky, Don Julio tequila, and Bundaberg rum. In addition, it offers beer under various brands, such as Malta Guinness non-alcoholic malt, Harp lager, Tu sker lager, Smithwick?s ale, Senator lager, and Red Stripe lager; and wine under a range of brands, including Blossom Hill, Sterling Vineyards, Beaulieu Vineyard, Navarro Correas, Acacia Vineyard, Rosenblum Cellars, Piat d?Or, Chalone Vineyard, and Santa Rita. Further, Diageo plc owns the distribution rights for the Jose Cuervo tequila brands in North America and internationally. The company was founded in 1886 and is based in London, the United Kingdom.
Advisors' Opinion:- [By John Udovich]
Whiskey has become increasingly cool and popular thanks to the whole cocktail movement, something that�� good for big whiskey stocks like Suntory Beverage & Food Limited (OTCMKTS: STBFY), Diageo plc (NYSE: DEO) and Brown-Forman Corporation (NYSE: BF.B) who�also produce a wide variety of�liquors and beverages. In fact,�a recent episode of the�Daily Ticker�cited these stats from a USA Today article:
- [By Nicole Seghetti]
Diageo's (NYSE: DEO ) recently upped stake in India's United Spirits�gives the liquor behemoth the leading position in the largest global whiskey market. Will this deal ensure big things to come for Diageo? Or is competition in the brown spirits market just bubbling up?
10 Best Asian Stocks To Own For 2014: Matahari Department Store Tbk PT (LPPF)
PT Matahari Department Store Tbk operates as a multi-format retailer. The Company, based in Indonesia, operates as the Department Store division of Matahari Putra Prima. The Matahari Group is Indonesia's multi-format retailer with core retail businesses in fashion and household groceries businesses targeted for middle - upper middle consumers throughout the country. Advisors' Opinion:- [By Emma O��rien]
PT Matahari Department Store (LPPF), Indonesia�� largest retailer, climbed 7.7 percent to 14,000 rupiah after the stock was added to the MSCI Emerging Markets Index.
10 Best Asian Stocks To Own For 2014: National Western Life Insurance Company(NWLI)
National Western Life Insurance Company provides life insurance products for the savings and protection needs of policyholders and annuity contracts for the asset accumulation and retirement needs of contract holders. Its life products include universal life insurance and interest-sensitive whole life, as well as traditional products, such as term insurance coverage; and annuity products comprise flexible premium and single premium deferred annuities, fixed indexed annuities, and single premium immediate annuities. The company markets and distributes its insurance products primarily through independent national marketing organizations to residents of various countries in central and South America, the Caribbean, the Pacific Rim, eastern Europe, and Asia. It also engages in small real estate, nursing home, and other investment operations. The company was founded in 1956 and is based in Austin, Texas.
Advisors' Opinion:- [By David Merkel]
The two stocks in question are Stancorp Financial (SFG) and National Western Life Insurance (NWLI). The short cases for both are based on a naive view of how insurance companies work.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, life insurance company National Western Life Insurance Company (NASDAQ: NWLI ) has earned a coveted five-star ranking.
10 Best Asian Stocks To Own For 2014: ICON plc(ICLR)
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, the United States, and rest of Europe. It specializes in strategic development, management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies. The company?s clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. Its clinical research services also comprise marker access and commercialization services, strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynam ic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, contract staffing, and electronic endpoint adjudication. In addition, the company offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.
Advisors' Opinion:- [By Louis Navellier]
European Stocks to Buy: ICON Public Limited (ICLR)
ICON Public Limited Company (ICLR) is a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, the United States, and Europe. They provide management, and analysis of programs that support various stages of clinical development process from compound selection to Phase I to IV clinical studies as well as lab services for companies conducting trials. The company has posted triple digit earnings gains and posted four consecutive positive earnings surprises in the past year. Analysts have been raising their estimates for the Irish company and Portfolio Grader raised the stock to an A last month. The stock is a strong buy at today�� price.
10 Best Asian Stocks To Own For 2014: Arotech Corporation(ARTX)
Arotech Corporation, together with its subsidiaries, provides defense and security products. It operates in three divisions: Training and Simulation, Battery and Power Systems, and Armor. The Training and Simulation division develops, manufactures, and markets multimedia and interactive digital solutions for use-of-force training and driving training of military, law enforcement, security, and other personnel; provides simulators, systems engineering, and software products to the United States military, government, and private industry; and offers specialized use of force training for police, security personnel, and the military. The Battery and Power Systems division manufactures and sells lithium and zinc-air batteries for defense and security products and other military applications; and develops and sells rechargeable and primary lithium batteries and smart chargers to the military and to private defense industry. This division also develops, manufactures, and markets primary zinc-air batteries, rechargeable batteries, and battery chargers for the military; and produces water-activated lifejacket lights for commercial aviation and marine applications. The Armor Division manufactures military and paramilitary armored vehicles, and employs sophisticated lightweight materials to produce aviation armor; and uses engineering concepts to produce combat armored military vehicles and up-armor civilian commercial vehicles. This division also uses lightweight armoring materials and advanced engineering processes to provide ballistic armor kits for rotary and fixed wing aircraft. Arotech sells its products primarily in the United States, Israel, Taiwan, Canada, England, Germany, Australia, China, Hong Kong, Mexico, India, Spain, Singapore, and Japan. The company was formerly known as Electric Fuel Corporation and changed its name to Arotech Corporation in September 2003. Arotech Corporation was founded in 1990 and is based in Ann Arbor, Michigan.
Advisors' Opinion:- [By Monica Gerson]
Arotech (NASDAQ: ARTX) dipped 7.50% to $4.07 in pre-market trading after dropping 2.22% on Wednesday.
ModusLink Global Solutions (NASDAQ: MLNK) fell 6.95% to $4.55 in pre-market trading after the company announced a proposed $75 million convertible senior notes offering.
- [By James E. Brumley]
Well, I can only give myself a C+ for my timing, but I'll still give myself an A for picking 'em. Today, nearly a month after a picked it, Arotech Corporation (NASDAQ:ARTX) shares are finally taking off. If my read on the ARTX is right - the same read I had in mid-May - this is just the beginning of a rewarding rally for the stock.
10 Best Asian Stocks To Own For 2014: Mecox Lane Limited(MCOX)
Mecox Lane Limited, through its subsidiaries, engages in the design and sale of apparel, accessories, and home and healthcare products through its online platform and stores in the People?s Republic of China. Its apparel and accessories include women?s T-shirts, sweaters, jeans, dresses, outerwear, purses, and shoes, as well as offers kids? apparels and men?s apparels. The company also provides home furnishings and other small household appliances; a large-rim cup to cook instant noodles; beauty and healthcare products, such as skin care, fragrance, cosmetics, and other personal care products; and pet-related and other products. It sells its products under Euromoda and Rampage brands, as well as under third-party brands. In addition, the company involves in the telephonic sale of garments, accessories, and other products; and wholesale and retail of garments. Further, it offers software development and information technology support services. As of December 31, 2010, t he company operated 451 stores, including 327 franchised stores and 124 directly operated stores in 172 cities. Mecox Lane Limited distributes its products through company-owned and franchised stores, as well as through its M18.com e-commerce Website. The company was founded in 1996 and is headquartered in Shanghai, the People?s Republic of China. Mecox Lane Limited is a subsidiary of Mecox Lane.
Advisors' Opinion:- [By Roberto Pedone]
Mecox Lane (MCOX) offers a selection of products apparel, accessories and home and health care products through its online platform and third party e-commerce websites. This stock closed up 13.5% to $4.10 in Tuesday's trading session.
Tuesday's Range: $3.62-$4.18
52-Week Range: $1.67-$7.88
Tuesday's Volume: 274,000
Three-Month Average Volume: 238,211From a technical perspective, MCOX exploded higher here right above some near-term support at $3.42 and back above its 50-day moving average of $4 with above-average volume. This stock has been trending sideways and consolidating over the last two months, with shares moving between $3.23 on the downside and $4.58 on the upside. This spike on Tuesday is quickly pushing shares of MCOX within range of breaking out above the upper-end of its recent range. That trade will hit if MCOX manages to clear Tuesday's high of $4.18 and then above more resistance at $4.58 with high volume.
Traders should now look for long-biased trades in MCOX as long as it's trending above its 200-day at $3.24 and then once it sustains a move or close above those breakout levels with volume that hits near or above 238,211 shares. If that breakout hits soon, then MCOX will set up to re-test or possibly take out its next major overhead resistance levels at $6 to its 52-week high at $7.88.
10 Best Asian Stocks To Own For 2014: Medivation Inc.(MDVN)
Medivation, Inc., a biopharmaceutical company, focuses on the development of small molecule drugs for the treatment of castration-resistant prostate cancer, Alzheimer?s disease, and Huntington disease. The company?s product candidates under clinical development include MDV3100, which is in Phase 3 development for the treatment of castration-resistant prostate cancer; and dimebon, which is in Phase 3 clinical trial for the treatment of Alzheimer?s disease and Huntington disease. It has collaboration agreements with Pfizer Inc. to develop and commercialize dimebon; and Astellas Pharma Inc. to develop and commercialize MDV3100. The company was founded in 2003 and is based in San Francisco, California.
Advisors' Opinion:- [By Sean Williams]
What: Shares of biopharmaceutical company Medivation (NASDAQ: MDVN ) sank as much as 11% after rival Johnson & Johnson (NYSE: JNJ ) announced it was purchasing Aragon Pharmaceuticals to get ahold of its experimental advanced prostate cancer drug, ARN-509.
No comments:
Post a Comment